Document is current
Any future updates will be listed below
-
Authors
Bashari, W. A.
van der Meulen, M.
MacFarlane, J.
Gillett, D.
Senanayake, R.
Serban, L.
Powlson, A. S.
Brooke, A. M.
Scoffings, D. J.
Jones, J.
O’Donovan, D. G.
Tysome, J.
Santarius, T.
Donnelly, N.
Boros, I.
Aigbirhio, F.
Jefferies, S.
Cheow, H. K.
Mendichovszky, I. A.
Kolias, A. G.
Mannion, R.
Koulouri, O.
Gurnell, M.
-
Funding
Funding for this research was provided by:
NIHR Cambridge Biomedical Research Center (BRC-1215-20014)
NIHR Cambridge Biomedical Research Center (BRC-1215-20014)
NIHR Cambridge Biomedical Research Center (BRC-1215-20014)
NIHR Cambridge Biomedical Research Center (BRC-1215-20014)
- License Information
-
More Information
Article History
Accepted: 3 May 2022
First Online: 24 May 2022
Declarations
:
: The authors declare no competing interests.
: Authors have no competing interests, or other interests that might be perceived to influence the results and/or discussion reported in this paper.
: The trial was conducted in accordance with Good Clinical Practice and the principles in the Declaration of Helsinki. The study received institutional approval from Cambridge University Hospitals NHS Foundation Trust (CUH QSIS 2020: 3039).
: All participants were appropriately consented before any study procedures.
: All authors approved the final manuscript for submission.
